Journal of Bone and Mineral Metabolism最新文献

筛选
英文 中文
Correction to: Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats. 校正:人甲状旁腺激素(1-34)与甲萘醌-4联合治疗对骨质疏松大鼠股骨羟基磷灰石包覆钛植入物界面的影响。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 DOI: 10.1007/s00774-024-01567-7
Hang Li, Qiang Zhou, Bing-Li Bai, She-Ji Weng, Zong-Yi Wu, Zhong-Jie Xie, Zhen-Hua Feng, Liang Cheng, Viraj Boodhun, Lei Yang
{"title":"Correction to: Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.","authors":"Hang Li, Qiang Zhou, Bing-Li Bai, She-Ji Weng, Zong-Yi Wu, Zhong-Jie Xie, Zhen-Hua Feng, Liang Cheng, Viraj Boodhun, Lei Yang","doi":"10.1007/s00774-024-01567-7","DOIUrl":"10.1007/s00774-024-01567-7","url":null,"abstract":"","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"186-188"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143189515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Osteoporosis screening using X-ray assessment and osteoporosis self-assessment tool for Asians in hip surgery patients. 用x线评估和骨质疏松自我评估工具筛查亚洲髋部手术患者的骨质疏松症。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 Epub Date: 2024-12-10 DOI: 10.1007/s00774-024-01569-5
Ryo Higuchi, Keisuke Uemura, Sotaro Kono, Hirokazu Mae, Kazuma Takashima, Hirohito Abe, Takashi Imagama, Takashi Sakai, Seiji Okada, Hidetoshi Hamada
{"title":"Osteoporosis screening using X-ray assessment and osteoporosis self-assessment tool for Asians in hip surgery patients.","authors":"Ryo Higuchi, Keisuke Uemura, Sotaro Kono, Hirokazu Mae, Kazuma Takashima, Hirohito Abe, Takashi Imagama, Takashi Sakai, Seiji Okada, Hidetoshi Hamada","doi":"10.1007/s00774-024-01569-5","DOIUrl":"10.1007/s00774-024-01569-5","url":null,"abstract":"<p><strong>Objectives: </strong>As many patients with osteoporosis remain undiagnosed, we aimed to develop a simple method to efficiently screen for osteoporosis using a combination of anteroposterior hip X-ray assessment and the Osteoporosis Self-Assessment Tool for Asians (OSTA), which is calculated as (body weight - age) × 0.2.</p><p><strong>Methods: </strong>One hundred Japanese women (age: 73 ± 11 years, body weight: 54.4 ± 11.1 kg) who underwent hip surgery, anteroposterior hip X-ray, and DXA were included. Based on the DXA results of the total proximal femur, 35 cases were diagnosed with osteoporosis. Fifteen orthopaedic surgeons visually inspected the hip X-ray images and scored the suspicion of osteoporosis on a scale of 1-4 (1: very unlikely, 4: very suspicious), which is referred to as \"pred-score.\" In addition, OSTA was calculated as a continuous variable (OSTA score). Osteoporosis was screened using the pred-score and OSTA score, and both scores were analyzed using the receiver operating characteristic curves.</p><p><strong>Results: </strong>The area under the curves (AUCs) of the pred-score and OSTA score were 0.626-0.875 and 0.817 across surgeons, respectively. When both scores were used, the AUC for screening osteoporosis ranged from 0.821 to 0.915 across surgeons. Significant improvement from AUCs calculated with the pred-score or OSTA score was found in 11 surgeons (73.3%).</p><p><strong>Conclusion: </strong>The combination of X-ray assessment and OSTA can be used to screen for osteoporosis and has the potential to be used as a new simple screening tool in daily clinical practice.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"158-165"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11993500/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142800889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia. 美克洛嗪和生长激素可改善软骨发育不全实验模型的骨长度和骨质量。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 Epub Date: 2024-11-08 DOI: 10.1007/s00774-024-01563-x
Kenta Sawamura, Masaki Matsushita, Ryusaku Esaki, Kenichi Mishima, Yasunari Kamiya, Kinji Ohno, Hiroshi Kitoh, Shiro Imagama
{"title":"Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia.","authors":"Kenta Sawamura, Masaki Matsushita, Ryusaku Esaki, Kenichi Mishima, Yasunari Kamiya, Kinji Ohno, Hiroshi Kitoh, Shiro Imagama","doi":"10.1007/s00774-024-01563-x","DOIUrl":"10.1007/s00774-024-01563-x","url":null,"abstract":"<p><strong>Introduction: </strong>Achondroplasia (ACH) is a common skeletal dysplasia associated with short-limbed short stature caused by gain-of-function mutations in the fibroblast growth factor receptor 3 (FGFR3) gene. Meclozine was found to inhibit FGFR3 signaling using a drug repositioning strategy. In some countries, growth hormone (GH) has been employed to ameliorate short stature in children with ACH. This study aims to investigate the effects of meclozine and GH on bone growth and quality using an experimental model of ACH.</p><p><strong>Materials and methods: </strong>Meclozine (2 mg/kg/day) and/or GH (0.35 mg/kg/day) were administered to a mouse model of ACH from the age of 7 to 56 days. Body length and body weight of each mouse were measured during these treatments. At the end of treatments, these mice were subjected to micro-computed tomography scans to measure the lengths of long bones and bone mineral density (BMD). The width of the growth plate was quantified by histological analysis.</p><p><strong>Results: </strong>The body and bone length of transgenic mice significantly increased after treatment with meclozine and GH, although there was no additive effect of the combination therapy on promoting bone growth. In contrast, BMD was additively increased by the combination therapy. The width of the growth plate in transgenic mice was significantly increased by both treatments, although the hypertrophic zone was enlarged by meclozine but not by GH.</p><p><strong>Conclusion: </strong>Meclozine or GH may be an option for treating children with ACH to ameliorate bone length and quality, but the additive effect would be limited.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"74-85"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Tea consumption and risk of bone health: an updated systematic review and meta-analysis. 修正:饮茶与骨骼健康风险:一项最新的系统综述和荟萃分析。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 DOI: 10.1007/s00774-024-01571-x
Fuding Zhou, Ting Wang, Lexun Li, Jinchuan Yu, Zhengxiang Liu, Jianghui Zhang, Guangjun Wang, Jiujiu Li, Changsheng Shao, Peng Wang, Wenjun Chen
{"title":"Correction: Tea consumption and risk of bone health: an updated systematic review and meta-analysis.","authors":"Fuding Zhou, Ting Wang, Lexun Li, Jinchuan Yu, Zhengxiang Liu, Jianghui Zhang, Guangjun Wang, Jiujiu Li, Changsheng Shao, Peng Wang, Wenjun Chen","doi":"10.1007/s00774-024-01571-x","DOIUrl":"10.1007/s00774-024-01571-x","url":null,"abstract":"","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"189"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142927090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges to implementing artificial intelligence-enabled Chest X-ray in opportunistic screening for osteoporosis. 在骨质疏松症的机会性筛查中实施人工智能胸部x线的挑战。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 Epub Date: 2025-01-11 DOI: 10.1007/s00774-025-01578-y
Hongnan Ye
{"title":"Challenges to implementing artificial intelligence-enabled Chest X-ray in opportunistic screening for osteoporosis.","authors":"Hongnan Ye","doi":"10.1007/s00774-025-01578-y","DOIUrl":"10.1007/s00774-025-01578-y","url":null,"abstract":"","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"182-183"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142965101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nationwide database study of postoperative sequelae and in-hospital mortality in super-elderly hip fracture patients. 关于超高龄髋部骨折患者术后后遗症和住院死亡率的全国性数据库研究。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 Epub Date: 2024-11-07 DOI: 10.1007/s00774-024-01564-w
Yu Mori, Kunio Tarasawa, Hidetatsu Tanaka, Naoko Mori, Kiyohide Fushimi, Toshimi Aizawa, Kenji Fujimori
{"title":"Nationwide database study of postoperative sequelae and in-hospital mortality in super-elderly hip fracture patients.","authors":"Yu Mori, Kunio Tarasawa, Hidetatsu Tanaka, Naoko Mori, Kiyohide Fushimi, Toshimi Aizawa, Kenji Fujimori","doi":"10.1007/s00774-024-01564-w","DOIUrl":"10.1007/s00774-024-01564-w","url":null,"abstract":"<p><strong>Introduction: </strong>The risk of postoperative sequelae and in-hospital mortality in Japanese patients aged 90 years and older with hip fractures is unexplored. This study aims to use a comprehensive medical claims database in Japan to compare super-elderly patients aged 90 years and older with elderly aged 65-89 and clarify the risk of sequelae and in-hospital mortality in super-elderly patients.</p><p><strong>Materials and methods: </strong>We retrospectively analyzed the Diagnosis Procedure Combination (DPC) database for all of Japan from April 2016 to March 2022. Medical records from approximately 1100 DPC-related hospitals were provided with consistent consent during this period. In this study, we focused on super-elderly patients and examined the association with the risk of postoperative pneumonia, pulmonary embolism, myocardial infarction, urinary tract infection, acute renal dysfunction, subsequent cognitive dysfunction, and in-hospital mortality after one-to-one propensity score matching.</p><p><strong>Results: </strong>After performing propensity score matching based on sex and comorbidities, 129,953 pairs of patients were identified. These pairs were compared to elderly and super-elderly patients. The results of this study showed that compared with hip fractures in the elderly, hip fractures in the super-elderly were associated with an increased risk of pneumonia, urinary tract infection, acute renal dysfunction, subsequent cognitive dysfunction, and in-hospital mortality after adjustment for confounders. The odds ratio of in-hospital mortality was 2.190 (95% CI 2.062-2.325).</p><p><strong>Conclusion: </strong>As it has been shown that super-elderly patients with hip fractures are at greater risk of respiratory and urinary tract infections and increased in-hospital mortality, careful attention should be required for perioperative management.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"141-148"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11993445/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to letter to the editor on "challenges to implementing artificial intelligence-enabled chest X-ray in opportunistic screening for osteoporosis". 回复致编辑关于“在骨质疏松症的机会性筛查中实施人工智能胸部x光的挑战”的信。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 Epub Date: 2025-02-17 DOI: 10.1007/s00774-025-01587-x
Norio Yamamoto, Akihiro Shiroshita
{"title":"Response to letter to the editor on \"challenges to implementing artificial intelligence-enabled chest X-ray in opportunistic screening for osteoporosis\".","authors":"Norio Yamamoto, Akihiro Shiroshita","doi":"10.1007/s00774-025-01587-x","DOIUrl":"10.1007/s00774-025-01587-x","url":null,"abstract":"","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"184-185"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143440789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights into skeletal involvement in adult Gaucher disease: a single-center experience. 成人戈谢病骨骼受累的见解:单中心经验。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 Epub Date: 2025-01-19 DOI: 10.1007/s00774-024-01573-9
Merve Yoldaş Çelik, Ebru Canda, Havva Yazıcı, Fehime Erdem, Ayşe Yüksel Yanbolu, Ayca Aykut, Asude Durmaz, Sema Kalkan Uçar, Eser Yıldırım Sözmen, Mahmut Çoker
{"title":"Insights into skeletal involvement in adult Gaucher disease: a single-center experience.","authors":"Merve Yoldaş Çelik, Ebru Canda, Havva Yazıcı, Fehime Erdem, Ayşe Yüksel Yanbolu, Ayca Aykut, Asude Durmaz, Sema Kalkan Uçar, Eser Yıldırım Sözmen, Mahmut Çoker","doi":"10.1007/s00774-024-01573-9","DOIUrl":"10.1007/s00774-024-01573-9","url":null,"abstract":"<p><strong>Introduction: </strong>Gaucher disease (GD) is a lysosomal storage disorder causing systemic and skeletal complications. This study evaluates bone health in adult GD type 1 patients, focusing on skeletal complications, bone mineral density (BMD), and biochemical markers.</p><p><strong>Material and methods: </strong>A cohort of adult GD type 1 patients followed up at Ege University Pediatric Metabolism Department were retrospectively examined.</p><p><strong>Results: </strong>This study included 32 patients with GD type 1, comprising 11 males (34.4%) and 21 females (65.6%). The median age at diagnosis was 20.5 years (min: 3-max:65), and at enrolment, it was 35 years (min:18-max:71). Most patients (93.8%) had organomegaly, and 93.8% had cytopenia. Common genetic variants were p.Asn409Ser (60.9%), p.Leu483Pro (7.8%), and p.Asp448His(4.7%). All patients were on enzyme replacement therapy (ERT) for a median of 11 years (min:2-max:18). Bone complications included pathologic fractures in six patients (19%) and avascular necrosis in 12 patients (37.5%). Bone pain was reported by 93.7% of patients at admission and persisted in 59.4% during follow-up. DXA scans showed abnormal bone mineral density (BMD) in 62.5% of patients initially, with a significantly low bone density in 3.1% and reduced bone density in 59.3%. BMD improved with treatment, as evidenced by a significant increase in Z scores (p < 0.05). Elevated chitotriosidase (75%), ferritin (50%), and immunoglobulin G (21.9%) levels were noted but did not correlate with BMD. Seven patients (22%) were splenectomized, all with bone issues.</p><p><strong>Discussion: </strong>Bone health in GD involves multiple factors beyond biochemical markers. While ERT improves BMD, bone pain and fractures remain significant issues. Comprehensive management, including regular BMD monitoring and better vitamin D supplementation adherence, is crucial. Further research is needed to improve treatments for bone complications in GD.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"166-173"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143005944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Serum albumin as a biomarker of (nutritional status in) sarcopenia. 血清白蛋白作为(肌肉疏松症营养状况的)生物标志物。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 Epub Date: 2024-11-08 DOI: 10.1007/s00774-024-01557-9
Kübra Erdoğan, Murat Kara, Fatıma Edibe Şener, Mahmut Esad Durmuş, Beyza Nur Çıtır Durmuşoğlu, Ahmad J Abdulsalam, Semih Sezer, Özgür Kara, Bayram Kaymak, Levent Özçakar
{"title":"Serum albumin as a biomarker of (nutritional status in) sarcopenia.","authors":"Kübra Erdoğan, Murat Kara, Fatıma Edibe Şener, Mahmut Esad Durmuş, Beyza Nur Çıtır Durmuşoğlu, Ahmad J Abdulsalam, Semih Sezer, Özgür Kara, Bayram Kaymak, Levent Özçakar","doi":"10.1007/s00774-024-01557-9","DOIUrl":"10.1007/s00774-024-01557-9","url":null,"abstract":"<p><strong>Introduction: </strong>To explore the possible associations between blood markers including albumin, hemoglobulin, creatinine and 25 OH vitamin D with sarcopenia using the ISarcoPRM algorithm.</p><p><strong>Materials and methods: </strong>A total of 2094 community-dwelling males and postmenopausal females (495 males, 1599 females)aged ≥ 50 years were recruited and their demographic data along with all comorbidities and laboratory evaluations were noted. Functional measurements were also quantified and the ISarcoPRM algorithm was used for the diagnosis/confirmation of the participants into sarcopenic and non-sarcopenic categories.</p><p><strong>Results: </strong>Sarcopenia was detected in 434 (20.7%) participants and low albumin level in 578 (27.6%) of them. While sarcopenia was detected in 193 (33.4%) of 578 subjects with low albumin levels, and in 241 (15.9%) of 1516 subjects with normal albumin levels (p < 0.001). In the binary logistic regression analysis, among the blood parameters; only albumin levels [OR: 0.932 (95% CI 0.876-0.992) in males (p = 0.026), OR: 0.901 (95% CI 0.862-0.941) in females (p < 0.001)were found to be independently associated with sarcopenia in each gender. After adjusting for sociodemographic and other clinical factors, having low albumin levels(≤ 4.0 g/dL) were independently associated with sarcopenia i.e. 2.368 times (95% CI 1.424-3.939) in males and 2.026 times (95% CI 1.520-2.699) in females (both p < 0.001).</p><p><strong>Conclusion: </strong>Independent of other factors, low albumin level is associated with sarcopenia i.e. at least two times in both genders. Older and obese adults at risk of malnutrition should be screened/diagnosed and treated early for sarcopenia. Prospective studies are needed for better/prompt management of relevant patients who are prone to significant morbidity and mortality.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"108-113"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142621092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aromatase inhibitors, bone microstructure, and estimated bone strength in postmenopausal women with breast cancer: a 5-year prospective study. 乳腺癌绝经后妇女的芳香化酶抑制剂、骨微结构和估计骨强度:一项为期 5 年的前瞻性研究。
IF 2.4 3区 医学
Journal of Bone and Mineral Metabolism Pub Date : 2025-03-01 Epub Date: 2024-11-07 DOI: 10.1007/s00774-024-01560-0
Sayaka Kuba, Ko Chiba, Kounosuke Watanabe, Megumi Matsumoto, Michi Morita, Momoko Akashi, Aki Yukutake, Yuki Hara, Ayako Fukushima, Eiko Inamasu, Ryota Otsubo, Kosho Yamanouchi, Kengo Kanetaka, Makoto Osaki, Keitaro Matsumoto, Susumu Eguchi
{"title":"Aromatase inhibitors, bone microstructure, and estimated bone strength in postmenopausal women with breast cancer: a 5-year prospective study.","authors":"Sayaka Kuba, Ko Chiba, Kounosuke Watanabe, Megumi Matsumoto, Michi Morita, Momoko Akashi, Aki Yukutake, Yuki Hara, Ayako Fukushima, Eiko Inamasu, Ryota Otsubo, Kosho Yamanouchi, Kengo Kanetaka, Makoto Osaki, Keitaro Matsumoto, Susumu Eguchi","doi":"10.1007/s00774-024-01560-0","DOIUrl":"10.1007/s00774-024-01560-0","url":null,"abstract":"<p><strong>Introduction: </strong>Aromatase inhibitors (AIs) are the standard treatment for early breast cancer (EBC) and are typical causative agents of cancer treatment-induced bone loss. However, the effects of long-term treatment with these drugs on bone microstructure remain unclear.</p><p><strong>Materials and methods: </strong>This prospective, single-arm observational study included postmenopausal, non-osteoporotic women with hormone receptor-positive EBC. Patients who underwent dual-energy X-ray absorptiometry (DXA), high-resolution peripheral quantitative computed tomography (HR-pQCT), and tartrate-resistant acid phosphatase-5b (TRACP-5b) or procollagen type I N-terminal propeptide levels were compared at baseline and at 60 months after commencing AI treatment.</p><p><strong>Results: </strong>Fifteen women were included in the study, with a median age of 58 years and a quartile range of 56.5-62.5 years. At 60 months, HR-pQCT revealed that the cortical area and thickness decreased with increased cortical porosity in the cortical bone. In addition, the number of trabeculae decreased and trabecular separation increased trabecular bones decreases, and trabecular bone separation opens, resulting in a decrease in the trabecular bone volume fraction. Total bone mineral density (BMD), trabecular volumetric BMD, and cortical volumetric BMD, and estimated bone strength significantly decreased. DXA BMD values significantly decreased in the total hip and femoral neck but not the lumbar spine. TRACP-5b values after 5 years of AI treatment showed a significant negative correlation with the rate of change in the total volumetric BMD in the distal tibia.</p><p><strong>Conclusion: </strong>Postmenopausal women who received AIs for 5 years for EBC experienced significant deterioration in the bone microstructure, BMD, and estimated bone strength.</p>","PeriodicalId":15116,"journal":{"name":"Journal of Bone and Mineral Metabolism","volume":" ","pages":"133-140"},"PeriodicalIF":2.4,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信